Senior Industry Executive joins Microtest Diagnostics

Kjell Kristiansen, former Phadia AB senior executive, has become Group Managing Director at Microtest Diagnostics as the company prepares to bring its in-vitro allergy and autoimmunity testing platform (ADAMTM) directly to GP’s, Clinics and small laboratories.

Mr. Kristiansen has worked within the medical diagnostic field for over 30 years, most notably with Sweden’s Pharmacia AB which subsequently became Phadia AB prior to its 2011 acquisition by Thermo Fisher for USD $3.5bn. He was Regional Director for Asia, one of Phadia’s fastest growing divisions and led business development within Pharmacia Diagnostics and as Managing Director for a number of companies within the Group.

Vito Levi D'Ancona, Executive Chairman said: "Kjell’s appointment comes at a significant point in the Company’s life as we prepare for the imminent launch of our ADAM™ testing platform and for driving growth in the Company thereafter. His track record in growing allergy and autoimmunity markets worldwide confirms his ability to help patients, doctors and laboratories better diagnose such diseases. We welcome him to the team."